Quince Therapeutics (QNCX) Price to Book (2019 - 2026)

Quince Therapeutics has reported Price to Book for 8 years, with the latest figure at 3.16 in Q2 2026.

• On a quarterly basis, Price to Book fell 937.78% year-over-year to 3.16 in Q2 2026; TTM through Jun 2026 was 3.16, a 937.78% decrease from a year earlier, with the FY2025 full-year figure at 0.26, down 291.5% from the prior year.
• Price to Book was 3.16 for Q2 2026 at Quince Therapeutics, down from 0.03 in the prior quarter.
• The five-year high for Price to Book was 4.19 in Q3 2025, with the low at 3.16 in Q2 2026.
• Average Price to Book over 5 years is 0.1, with a median of 0.03 recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Price to Book jumped 11119.6% in 2025, then plunged 937.78% in 2026.
• Over 5 years, Price to Book stood at 0.01 in 2022, then soared by 131.61% to 0.03 in 2023, then soared by 414.68% to 0.14 in 2024, then sank by 291.5% to 0.26 in 2025, then tumbled by 1108.36% to 3.16 in 2026.
• The last three Price to Book figures came in at 3.16 (Q2 2026), 0.03 (Q1 2026), and 0.26 (Q4 2025), per Business Quant data.